Division of Gastroenterology, Hepatology and Endoscopy. Brigham and Women's Hospital. Boston, MA.
Harvard Medical School, Boston, MA.
Ann Surg. 2021 Apr 1;273(4):667-675. doi: 10.1097/SLA.0000000000003977.
The aim of this study was to perform a structured systematic review and meta-analysis to evaluate the effectiveness and complication rate of cholecystectomy deferral versus prophylactic cholecystectomy among patients post-endoscopic biliary sphincterotomy for common bile duct stones.
Although previous reports suggest a decreased risk of biliary complications with prophylactic cholecystectomy, biliary endoscopic cholangiopancreatography (ERCP) with sphincterotomy may provide a role for deferring cholecystectomy with the gallbladder left in situ.
Searches of PubMed, EMBASE, Web of Science, and Cochrane Library databases were performed through August 2019 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology guidelines. Measured outcomes included: mortality, recurrent biliary pain or cholecystitis, pancreatitis, cholangitis, and eventual need for cholecystectomy. Random effects models were used to determine pooled effect size and corresponding 95% confidence intervals (CIs).
Nine studies (n = 1605) were included. A total of 53.8% (n = 864) patients had deferred cholecystectomy post-sphincterotomy. Deferral cholecystectomy as compared to prophylactic cholecystectomy resulted in a significant increased risk of mortality [odds raio (OR) 2.56 (95% confidence interval, CI 1.54-4.23); P < 0.0001; I2 = 18.49]. Patients who did not undergo prophylactic cholecystectomy developed more recurrent biliary pain or cholecystitis [OR 5.10 (95% CI 3.39-7.67); P < 0.0001; I2 = 0.00]. Rate of pancreatitis [OR 3.11 (95% CI 0.99-9.83); P = 0.053; I2 = 0.00] and cholangitis [OR 1.49 (95% CI 0.74-2.98); P = 0.264; I2 = 0.00] was unaffected. Overall, 26.00% (95% CI 14.00-40.00) of patients with deferred prophylactic cholecystectomy required eventual cholecystectomy.
Prophylactic cholecystectomy remains the preferred strategy compared to a deferral approach with gallbladder in situ post-sphincterotomy for patients with bile duct stones. Future studies may highlight a subset of patients (ie, those with large balloon biliary dilation) that may not require cholecystectomy.
本研究旨在进行系统的综述和荟萃分析,以评估内镜下胆道括约肌切开术后胆总管结石患者中胆囊切除术延迟与预防性胆囊切除术的有效性和并发症发生率。
尽管先前的报告表明预防性胆囊切除术可降低胆道并发症的风险,但胆道内镜逆行胰胆管造影(ERCP)加括约肌切开术可能为保留胆囊原位的胆囊切除术提供了一种作用。
根据系统评价和荟萃分析的首选报告项目以及观察性研究荟萃分析的指南,通过 2019 年 8 月对 PubMed、EMBASE、Web of Science 和 Cochrane 图书馆数据库进行了搜索。测量结果包括:死亡率、复发性胆绞痛或胆囊炎、胰腺炎、胆管炎和最终需要胆囊切除术。使用随机效应模型确定汇总效应大小和相应的 95%置信区间(CI)。
共纳入 9 项研究(n=1605 例)。共有 53.8%(n=864 例)的患者在括约肌切开术后接受了胆囊切除术延迟。与预防性胆囊切除术相比,胆囊切除术延迟导致死亡率显著增加[比值比(OR)2.56(95%置信区间,CI 1.54-4.23);P<0.0001;I2=18.49]。未行预防性胆囊切除术的患者发生复发性胆绞痛或胆囊炎的风险更高[OR 5.10(95%CI 3.39-7.67);P<0.0001;I2=0.00]。胰腺炎[OR 3.11(95%CI 0.99-9.83);P=0.053;I2=0.00]和胆管炎[OR 1.49(95%CI 0.74-2.98);P=0.264;I2=0.00]的发生率无差异。总体而言,26.00%(95%CI 14.00-40.00)的患者需要最终进行预防性胆囊切除术。
与括约肌切开术后保留胆囊原位的方法相比,预防性胆囊切除术仍然是胆管结石患者的首选策略。未来的研究可能会突出显示一组不需要胆囊切除术的患者(例如,那些接受大球囊胆道扩张的患者)。